Antares Pharma Announces FDA Acceptance of IND Application for ATRS-1902 for Adrenal Crisis Rescue
22 juil. 2021 08h30 HE
|
Antares Pharma, Inc.
EWING, N.J., July 22, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration...
Antares Pharma to Present at the Ladenburg Thalmann Annual Healthcare Conference
07 juil. 2021 08h30 HE
|
Antares Pharma, Inc.
EWING, N.J., July 07, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced that Robert F. Apple, President and Chief...
Antares Pharma Announces Partner Idorsia Initiates the Phase 3 Study With Selatogrel for Acute Myocardial Infarction
28 juin 2021 08h30 HE
|
Antares Pharma, Inc.
EWING, N.J., June 28, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced that its partner Idorsia Ltd (“Idorsia”)...
Antares Pharma Announces Submission of IND Application for ATRS-1902 for Adrenal Crisis Rescue
22 juin 2021 09h00 HE
|
Antares Pharma, Inc.
EWING, N.J., June 22, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced that it has submitted an Investigational New...
Antares Pharma to Present at the Raymond James Human Health Innovations Conference
15 juin 2021 08h30 HE
|
Antares Pharma, Inc.
EWING, N.J., June 15, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced that Robert F. Apple, President and Chief...
Antares Pharma to Present at the Jefferies Virtual Healthcare Conference
26 mai 2021 08h30 HE
|
Antares Pharma, Inc.
EWING, N.J., May 26, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced that Robert F. Apple, President and Chief...
Antares Pharma Appoints Joseph Renda as Senior Vice President of Commercial
06 mai 2021 07h15 HE
|
Antares Pharma, Inc.
EWING, N.J., May 06, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced the appointment of Joseph V. Renda as Senior...
Antares Pharma Reports First Quarter 2021 Financial and Operating Results
06 mai 2021 07h00 HE
|
Antares Pharma, Inc.
Increased Revenue 27% Year-Over-Year to $42.1 Million Increased Net Income to $3.8 Million, or $0.02 Per Basic and Diluted Earnings Per Share EWING, N.J., May 06, 2021 (GLOBE NEWSWIRE) -- Antares...
Antares Pharma Announces Poster Presentation at the Pediatric Endocrine Society 2021 Virtual Annual Meeting
03 mai 2021 08h30 HE
|
Antares Pharma, Inc.
EWING, N.J., May 03, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced that data highlighting the therapeutic...
Antares Pharma to Participate in the 7th Annual Truist Securities 2021 Life Sciences Summit
28 avr. 2021 08h30 HE
|
Antares Pharma, Inc.
EWING, N.J., April 28, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced that Robert F. Apple, President and Chief...